Wednesday, November 10, 2021 7:00:53 AM
Literature Database
Blood purification during valve surgery for infective endocarditis in an adolescent
Theodor Tirilomis | Thoracic and Cardiovascular Surgery, University of Goettingen, Goettingen, Germany | Artificial Organs. 2021; 45:95–96
11/10/2021
New!PediatricsPeer Reviewed Published DataReduction in catecholaminesSafetyAortic SurgeryCardiac surgeryCase of the weekCase reportCPBEndocarditisInflammatory parametersIntra-Op
Download documentDownload documentLink to source
Summary
CoW 45/2021 – This case reports on a 15-year old boy with history of bicuspid valve and mild aortic valve regurgitation, who had a recent history of abdominal pain, diarrhea, and vomiting.
Case presentation
With an increasing reduction in vigilance and the development of visual hallucinations, he was first admitted to a peripheral hospital, and then transferred to University of Goettingen
The clinical examination showed multiple skin emboli
Additionally, computed tomography scans and magnetic resonance imaging showed embolic infarctions in various organs including brain, kidneys, liver, and spleen
Examination of cerebrospinal fluid revealed clear liquid, but cell count and lactate were increased (50 cells per µL and 3.3 mmol/L, respectively)
The patient was admitted to the pediatric intensive care unit (PICU) and antibiotic therapy along with antiviral treatment was initiated
Transthoracic echocardiogram was initially assessed as unremarkable but in the course an increasing aortic insufficiency was seen
Therefore transesophageal echocardiography was performed which showed endocarditic vegetations of the aortic valve
Because of this finding and the increased risk of further embolic events, the patient underwent urgent cardiopulmonary bypass (CPB) assisted aortic valve surgery. During the operation, the diseased aortic valve was found to have two large endocarditic vegetations; one on the rudimental raphe between left-coronary and right-coronary leaflet and another one on ventricular side of noncoronary leaflet. The infected valve was excised and replaced
Additionally, a CytoSorb adsorber was installed into the CPB circuit due to the high risk of him developing septic shock postoperatively from the infective endocarditis, and also the possibility of an additional inflammatory reaction due to the operation itself
Treatment
One hemoadsorption treatment for the entire cardiopulmonary bypass time (102 mins),
CytoSorb was installed in the CPB circuit using a side arm coming from the venous cannula
CPB pump flow: 2.5 L/ min/m2
Measurements
Hemodynamics and vasopressor requirements (norepinephrine, epinephrine)
Free hemoglobin levels
Results
Treatment resulted in a hemodynamic stabilization as evidenced by constant and then increasing arterial blood pressure while vasopressor dosages decreased. Norepinephrine support was terminated 4 hours after surgery and epinephrine 24 hours later
Free hemoglobin level increased preoperatively from 16 to 28 mg/dL immediately after surgery and finally decreased 6 hours later to 15 mg/dL
Patient Follow-up
Microbial examination of valve tissue as well the blood cultures taken before surgery identified Staphylococcus aureus and the antibiotic treatment was adapted accordingly with flucloxacillin, rifampicin, and clindamycin
His postoperative PICU and hospital stay was uneventful
Conclusion
In this case of a pediatric patient undergoing valve surgery for endocarditis, the application of CytoSorb hemoadsorption treatment was associated with rapid and sustained hemodynamic stabilization
According to the authors this case shows that the prophylactic use of blood purification during CPB might have protective effects in the treatment of pediatric infective endocarditis
Nevertheless, further clinical studies are needed to assess optimal timing of treatment initiation.
Recent CTSO News
- CytoSorbents to Present at the H.C. Wainwright 26ᵗʰ Annual Global Investment Conference • GlobeNewswire Inc. • 08/27/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/20/2024 08:51:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/16/2024 10:58:42 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/16/2024 10:57:45 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/16/2024 09:28:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/16/2024 09:12:04 PM
- CytoSorbents Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 08/16/2024 08:05:00 PM
- CytoSorbents Reports Second Quarter 2024 Financial and Operational Results • GlobeNewswire Inc. • 08/13/2024 08:19:55 PM
- CytoSorbents Appoints Peter J. Mariani Chief Financial Officer • GlobeNewswire Inc. • 08/13/2024 08:18:28 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2024 08:04:32 PM
- CytoSorbents to Report Second Quarter 2024 Operating and Financial Results • GlobeNewswire Inc. • 08/07/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2024 08:12:56 PM
- CytoSorbents Announces Compliance with Nasdaq Minimum Bid Price Requirement • GlobeNewswire Inc. • 08/01/2024 11:00:00 AM
- CytoSorbents Unveils Newly Redesigned, Unified Company and Product Website • GlobeNewswire Inc. • 07/29/2024 12:00:00 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 07/26/2024 09:14:03 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/26/2024 09:11:21 PM
- CytoSorbents to Present at the Inaugural American Association of Physicians of Indian Origin (AAPI) World Health Congress • GlobeNewswire Inc. • 07/17/2024 11:00:00 AM
- CytoSorbents Secures $20 Million Credit Facility • GlobeNewswire Inc. • 07/02/2024 11:00:00 AM
- CytoSorbents Announces Regulatory Approval of CytoSorb® in Taiwan • GlobeNewswire Inc. • 06/24/2024 11:00:00 AM
- CytoSorbents Announces the Launch and Immediate Availability of the PuriFi™ Blood Pump in the European Union • GlobeNewswire Inc. • 06/13/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/10/2024 08:31:20 PM
- CytoSorbents to Host its 2024 Virtual Annual Stockholders Meeting • GlobeNewswire Inc. • 06/05/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2024 08:35:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 09:23:00 PM
- CytoSorbents Reports First Quarter 2024 Results • GlobeNewswire Inc. • 05/09/2024 08:17:23 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM